Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.76% | -76.37% | -4.15% | 42.98% | 56.52% |
| Total Depreciation and Amortization | 0.00% | 4.35% | 4.55% | 4.76% | -4.55% |
| Total Amortization of Deferred Charges | 22.22% | -43.75% | -3.03% | 3.13% | -3.03% |
| Total Other Non-Cash Items | 135.71% | 115.38% | 107.43% | -203.55% | -84.76% |
| Change in Net Operating Assets | -83.76% | 81.62% | 37.65% | 1,044.44% | 60.00% |
| Cash from Operations | -121.03% | -114.00% | 70.24% | 28.96% | -7.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -6.50% | -- | -- | -- | -- |
| Total Debt Repaid | 40.29% | -202.17% | -2.22% | 70.78% | -275.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.41% | -- | -- | -- | -- |
| Cash from Financing | 790.91% | 195.65% | -123.47% | 227.27% | -275.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.35% | -16.44% | -4.29% | 77.67% | -30.90% |
